New X-ray imaging developed by scientists
Scientists have developed an x-ray imaging system that enables researchers to see 'live' how effective treatments are for cystic fibrosis.
Aug 15, 2014
0
0
Scientists have developed an x-ray imaging system that enables researchers to see 'live' how effective treatments are for cystic fibrosis.
Aug 15, 2014
0
0
Cystic Fibrosis is a devastating genetic disease which afflicts over 10,000 children across the country. The disease results in a declining lung function, which in turn leads to a higher likelihood of developing lung infections. ...
Aug 12, 2014
0
0
Despite claiming an estimated 40,000 lives annually - roughly the same number as breast cancer or prostate cancer - pulmonary fibrosis remains one of the least known covert killers in the country.
Aug 12, 2014
0
0
Federal health regulators have approved a novel device that can preserve donated lungs outside the body for possible transplantation into critically ill patients.
Aug 12, 2014
0
0
A Queen's University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers.
Jun 26, 2014
0
0
This spring has brought rare but tangible moments of progress against the devastating lung disease idiopathic pulmonary fibrosis (IPF), which afflicts millions of people worldwide. Two drugs recently showed promise in clinical ...
Jun 11, 2014
0
0
(HealthDay)—An otherwise healthy man died of an incurable lung disease after breathing in fine particles while making Corian countertops for almost two decades, doctors report in the New England Journal of Medicine.
May 28, 2014
1
0
(Medical Xpress)—A common antioxidant had no effect on lung function compared to a placebo in patients with a chronic, progressive respiratory disease, according to research led by Weill Cornell Medical College and the ...
May 20, 2014
0
0
(HealthDay)—A pair of drugs offers new hope to patients with a progressive, fatal disease that robs their breath by scarring the lungs, according to clinical trial results.
May 18, 2014
0
0
PTC Therapeutics, Inc. today announced that the results of a Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis (nmCF) were published in Lancet Respiratory Medicine. The results demonstrated positive ...
May 16, 2014
0
0